Pneumococcal (black bars) and influenza (white bars) vaccine coverage in patients living with comorbidities (A), and immunosuppressive conditions (B), who are at risk of pneumococc... حسب Benjamin Wyplosz (22032756)

الموضوعات:

The sentiment score and number of tweets per month from 09/01/2018 to 01/31/2020. حسب Yuqi Zhang (286958)

الموضوعات:

Study population: patients living with comorbidities (on the left) and immunosuppressive conditions (on the right) who are at risk of pneumococcal disease in France in the year 202... حسب Benjamin Wyplosz (22032756)

الموضوعات:

Characteristics associated with pneumococcal primary vaccination (A) and 2020−21 seasonal influenza vaccination (B) in patients with comorbidities in France in 2020 (multivariable... حسب Benjamin Wyplosz (22032756)

الموضوعات:

The theme, top terms, and description of five topic groups. حسب Yuqi Zhang (286958)

الموضوعات:

Characteristics of patients at risk of pneumococcal disease in France in 2020 and vaccination rates. حسب Benjamin Wyplosz (22032756)

الموضوعات:

Volume distribution and sentiment of positive, negative, and neutral tweets. حسب Yuqi Zhang (286958)

الموضوعات:

Kaplan-Meier curves and time-dependent Cox regression for outcome of mortality. حسب Jennifer M. Kwan (3350321)

الموضوعات:

Cox regression models for adverse cardiovascular events (ACE) and individual components of ACE. حسب Jennifer M. Kwan (3350321)

الموضوعات:

Adverse cardiovascular events by immune checkpoint inhibitor. حسب Jennifer M. Kwan (3350321)

الموضوعات:

Baseline demographics and comorbidities by presence of post-treatment adverse cardiovascular events. حسب Jennifer M. Kwan (3350321)

الموضوعات:

Minimal dataset. حسب Jennifer M. Kwan (3350321)

الموضوعات:

Colon length changes according to IBD-exacerbated factors in Il2rg-deficient mice. حسب Sun-Min Seo (13154880)

Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70). حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

Distribution of quality of life and respiratory variables scores of all 3 visits (visit = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group... حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

The baseline characteristics of classifications and body condition score of the 2 groups (frequencies) at entry (visit 1, day 0). حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mea... حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

Tricuspid regurgitation pressure gradient of all 17 dogs. حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

Tricuspid regurgitation pressure gradient in the PCSO-524 and placebo groups. حسب Nattapon Riengvirodkij (11268720)

الموضوعات: